Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-07-07
1999-11-09
Elliott, George C.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
514 44, C07H 2100, A61K 3170
Patent
active
059817313
ABSTRACT:
Oligonucleotides are provided which are targeted to nucleic acids encoding human raf and capable of inhibiting raf expression. Methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided. The present invention further comprises methods of preventing or inhibiting hyperproliferation of cells and methods of treating abnormal proliferative conditions which employ oligonucleotides of the invention.
REFERENCES:
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5138045 (1992-08-01), Cook et al.
patent: 5218105 (1993-06-01), Cook et al.
patent: 5378825 (1995-01-01), Cook et al.
patent: 5459255 (1995-10-01), Cook et al.
patent: 5563255 (1996-10-01), Monia et al.
patent: 5585479 (1996-12-01), Hoke et al.
patent: 5591721 (1997-01-01), Agrawal et al.
patent: 5744362 (1998-04-01), Monia et al.
Gewirtz et al. Facilitating oligonucleotide delivery: Helping antisense deliver on its promise. Proc. Natl. Acad. Sci. USA 93: 3161-3163, Apr. 1996.
Inoue et al. Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNAse H. FEBS Letts. 215(2): 327-330, May 1987.
Milligan et al. Current concpts in antisense drug design. J. Med. Chem. 36(14): 1923-1937, Jul. 1993.
Milner et al. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nature Biotechnol. 15: 537-541, Jun. 1997.
Ahmad et al., "Antisense Expression of Protein Kinase C.alpha. Inhibits the Growth and Tumorigenicity of Human Glioblastoma Cells", Neurosurg., 1994, 35, 904-908.
Catalog of Products for DNA Research, Glen Research, Sterling VA, 1993, p. 21.
Chiang et al., "Antisense Oligonucleotides Inhibit Intercellular Adhesion Molecule 1 Expression by Two Distinct Mechanisms", J. Biol. Chem., 1991, 266, 18162-18171.
De Mesmaeker et al., "Antisense Oligonucleotides", Acc. Chem. Res., 1995, 28,366-374.
Gebeyehu, G. et al., "Novel biotinylated nucleotide--analogs for labeling and colorimetric detection of DNA", Nucl. Acids Res., 1987, 15, 4513-4534.
Kabanov et al., "A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells", FEBS Lett., 1990, 259, 327-330.
Kawasaki et al., "Uniformly Modified 2'-Deoxy-2'-fluoro Phosphorothioate Oligonucleotides as Nuclease-Resistant Antisense Compounds with High Affinity and Specificity for RNA Targets ", J. Med. Chem., 1993, 36, 831-841.
Kingston, R.E., in Current Protocols in Molecular Biology, (F.M. Ausubel et al., eds.), John Wiley and Sons, NY, 1993.
Kornberg, A., DNA Replication, W.H. Freeman & Co., San Francisco, 1980, pp. 75-77.
Letsinger et al., "Cholesteryl-conjugated oligonucleotides: Synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture", Proc. Natl. Acad. Sci. USA, 1989, 86, 6553-6556.
Maister, P., "Isis' Antisense Drug Shows Promise for Retinitis", BioWorld Today, Apr. 29, 1994, p.3.
Manoharan et al., "Cholic Acid-Oligonucleotide Conjugates for Antisense Applications", Bioorg. Med. Chem. Let., 1994, 4, 1053-1060.
Manoharan et al., "Chemical Modifications to Improve Uptake and Bioavailability of Antisense Oligonucleotides ", Ann. N.Y. Acad. Sci., 1992, 660, 306-309.
Manoharan et al., "Introduction of a Lipophilic Thioether Tether in the Minor Groove of Nucleic Acids for Antisense Applications", Bioorg. Med. Chem. Let., 1993, 3, 2765-2770.
Manoharan et al., "Oligonucleotide Conjugates: Alteration of the Pharmacokinetic Properties of Antisense Agents", Nucleosides & Nucleotides, 1995, 14, 969-973.
Manoharan et al., "Lipidic Nucleic Acids", Tetrahedron Lett., 1995, 36, 3651-3654.
Marais et al., "Differential Regulation of Raf-1, A-Raf and B-Raf by Oncogenic Ras and Tyrosine Kinases", J. Biol. Chem. 1997, 272, 4378-4383.
Martin, P., "Ein neuer Zugang zu 2'-O -Alkylribonucleosiden und Eigenschaften deren Oligonucleotide", Helv. Chim. Acta, 1995, 78, 486-504.
Monia et al., "Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase", Nature Med., 1996, 2, 668-675.
Nielsen et al., "Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide", Science, 1991, 254, 1497-1500.
Oberhauser et al., "Effective incorporation of 2'-O-methyl-oligoribonucleotides into liposomes and enhanced cell association through modification with thiocholesterol", Nucl. Acids Res., 1992, 20, 533-538.
Rapp et al., The Oncogene Handbook, E.P. Reddy, A.M Skalka and T. Curran, eds., Elsevier Science Publishers, New York, 1988, pp. 213-253.
Riedel et al., "The mitogenic response of T cells to interleukin-2 requires Raf-1", Eur. J. Immunol. 1993, 23, 3146-3150.
Sanghvi, Y.S., in Crooke, S.T. and Lebleu, B., eds., Antisense Research and Applications, CRC Press, Boca Raton, 1993, pp. 276-278.
Sanghvi et al., "Antisense oligodeoxynucleotides: synthesis, biophysical and biological evaluation of oligodeoxynucleotides containing modified pyrimidines", Nucl. Acids Res., 1993, 21, 3197-3203.
Saison-Behmoaras et al., "Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation", EMBO J., 1991, 10, 1111-1118.
Svinarchuk et al., "Inhibition of HIV proliferation in NT-4 cells by antisense oligonucleotide conjugated to lipophilic groups", Biochimie, 1993, 75, 49-54.
Sambrook et al., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, p. 10.59, 11.31-11.32.
Tornkvist et al., "Inhibition of Raf-1 Kinase Expression Abolishes Insulin Stimulation of DNA Synthesis in H4IIE Hepatoma Cells", J. Biol. Chem. 1994, 269,13919-13921.
Elliott George C.
ISIS Pharmaceuticals Inc.
Larson Thomas G.
LandOfFree
Antisense oligonucleotide modulation of B-raf gene expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotide modulation of B-raf gene expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide modulation of B-raf gene expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1457795